Early outcome after glenn shunt and fontan palliation and the impact of operation during viral respiratory season: Analysis of a 19-year multi-institutional experience

Annals of Thoracic Surgery

Volumn 79, Issue 2, 2005, Pages 613-617

  Nicolas, Ramzi T ^a,d   Hills, Christine ^c   Moller, James H ^c   Huddleston, Charles B ^b   Johnson, Mark C ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DATA ANALYSIS; FONTAN PROCEDURE; GLENN SHUNT; HEART SURGERY; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MEDICAL RECORD; OPERATION DURATION; PALLIATIVE THERAPY; PLEURA EFFUSION; PRIORITY JOURNAL; SHUNTING; SURGICAL MORTALITY; SURGICAL PATIENT; SURGICAL TECHNIQUE; VIRUS INFECTION;

CARDIAC SURGICAL PROCEDURES; COMOROS; FONTAN PROCEDURE; HOSPITAL MORTALITY; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA, HUMAN; LENGTH OF STAY; PALLIATIVE CARE; PLEURAL EFFUSION; RETROSPECTIVE STUDIES; SEASONS; TREATMENT OUTCOME;

EID: 13244292417     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2004.07.004     Document Type: Article

References (18)

1. S. Malviya, T. Voepel-Lewis, M. Siewert, U. Pandit, L. Riegger, A. Tait Risk factors for adverse postoperative outcomes in children presenting for cardiac surgery with upper respiratory tract infections Anesthesiology 98 2003 628 632
2. A. Khongphatthanayothin, P.C. Wong, Y. Samara Impact of respiratory syncytial virus infection on surgery for congenital heart disease: postoperative course and outcome Crit Care Med 27 1999 1974 1981
3. S.S. Long Respiratory syncytial virus J.A. McMillan C.D. DeAngelis R.D.M. Feigin Oski's pediatrics: Principles and practice 1999 Lippincott Williams & Wilkins Philadelphia 1094 1098
4. B.J. Law, X. Carbonell-Estrany, E. Simoes An update on respiratory syncytial virus epidemiology: a developed country perspective Resp Med 96 Suppl. B 2002 1 7
5. Fedderly RT, Whitstone BN, Frisbee SJ, Tweddell JS, Litwin SB. Factors related to pleural effusions after Fontan procedure in the era of fenestration. Circulation 2001;104(Suppl):I148-51.
6. T. Gentles, J. Mayer, K. Gauvreau Fontan operation in five hundred consecutive patients: factors influencing early and late outcome J Thorac Cardiovasc Surg 114 Suppl 1997 376 391
7. M.S. Lemler, W.A. Scott, S.R. Leonard, D. Stromberg, C. Ramaciotti Fenestration improves clinical outcome of the Fontan procedure: a prospective, randomized study Circulation 105 2002 207 212
8. H. Yamauchi, H. Imura, Y. Maruyama Evolution of staged approach for Fontan operation J Nippon Med Sch 69 2002 154 159
9. S. Tokunaga, H. Kado, Y. Imoto Total cavopulmonary connection with an extracardiac conduit: experience with 100 patients Ann Thorac Surg 73 2002 76 80
10. A.W. Gale, G.K. Danielson, D.C. McGoon, R.B. Wallace, D.D. Mair Fontan procedure for tricuspid atresia Circulation 62 1980 91 96
11. D.D. Mair, F.J. Puga, G.K. Danielson The Fontan procedure for tricuspid atresia: early and late results of a 25-year experience with 216 patients J Am Coll Cardiol 37 2001 933 939
12. F. Cetta, R.H. Feldt, P.W. O'Leary Improved early morbidity and mortality after Fontan operation: the Mayo Clinic experience, 1987 to 1992 J Am Coll Cardiol 28 1996 480 486
13. A.K. Pridjian, A.M. Mendelsohn, F.M. Lupinetti Usefulness of the bi-directional Glenn procedure as staged reconstruction for the functional single ventricle Am J Cardiol 71 1993 959 962
14. Choussat A, Fontan F, Besse P. Selection criteria for Fontan's procedure. In: Anderson RH, Shinebourne EA, eds. Pediatric cardiology 1997. Edinburgh: Churchill Livingstone, 1978:559-566.
15. H. Senzaki, C. Naito, T. Kobayashi Influence of age (body size) on the Fontan circulation--analysis by a theoretical model Jpn Circ J 64 2000 943 948
16. R. Jaquiss, N. Ghanayem, G. Hoffman Early cavopulmonary anastomosis in very young infants after the Norwood procedure: impact on oxygenation, resource utilization, and mortality J Thorac Cardiovasc Surg 127 2004 982 988
17. H.C. Meissner, S.S. Long American Academy of Pediatrics committee on infectious diseases and committee on fetus and newborn Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections Pediatrics 112 2003 1447 1452
18. Cabalka AK. Physiologic risk factors for respiratory viral infections and immunoprophylaxis for respiratory syncytial virus in young children with congenital heart disease. Pediatr Infect Dis J 2004;23(Suppl):S41-5.